Skip to main content
. 2010 Oct 7;34(1):27–33. doi: 10.2337/dc10-0531

Figure 2.

Figure 2

Mean ± SE observed A1C values during the 2-year intervention period in patients randomized to treatment with either NPH insulin (black symbols) or insulin aspart (open symbols) in combination with placebo (A, P < 0.001), metformin (B, P = 0.15), rosiglitazone (C, P < 0.02), or metformin and rosiglitazone (D, P = 0.15).